Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Factors Associated with Leaving Hospital against Medical Advice among People Who Use Illicit Drugs in Vancouver, Canada

  • Lianping Ti,

    Affiliations British Columbia Centre for Excellence in HIV/AIDS, St. Paul’s Hospital, 1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6, Department of Medicine, University of British Columbia, 2775 Laurel Street, Vancouver, BC, Canada V5Z 1M9

  • M-J Milloy,

    Affiliations British Columbia Centre for Excellence in HIV/AIDS, St. Paul’s Hospital, 1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6, Department of Medicine, University of British Columbia, 2775 Laurel Street, Vancouver, BC, Canada V5Z 1M9

  • Jane Buxton,

    Affiliations School of Population and Public Health, University of British Columbia, 2206 East Mall, Vancouver, BC, Canada V6T 1Z3, British Columbia Centre for Disease Control, 655 West 12th Avenue, Vancouver, BC, Canada V5Z 4R4

  • Ryan McNeil,

    Affiliation British Columbia Centre for Excellence in HIV/AIDS, St. Paul’s Hospital, 1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6

  • Sabina Dobrer,

    Affiliation British Columbia Centre for Excellence in HIV/AIDS, St. Paul’s Hospital, 1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6

  • Kanna Hayashi,

    Affiliations British Columbia Centre for Excellence in HIV/AIDS, St. Paul’s Hospital, 1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6, Department of Medicine, University of British Columbia, 2775 Laurel Street, Vancouver, BC, Canada V5Z 1M9

  • Evan Wood,

    Affiliations British Columbia Centre for Excellence in HIV/AIDS, St. Paul’s Hospital, 1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6, Department of Medicine, University of British Columbia, 2775 Laurel Street, Vancouver, BC, Canada V5Z 1M9

  • Thomas Kerr

    uhri-tk@cfenet.ubc.ca

    Affiliations British Columbia Centre for Excellence in HIV/AIDS, St. Paul’s Hospital, 1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6, Department of Medicine, University of British Columbia, 2775 Laurel Street, Vancouver, BC, Canada V5Z 1M9

Abstract

Background

Leaving hospital against medical advice (AMA) is common among people who use illicit drugs (PWUD) and is associated with severe health-related harms and costs. However, little is known about the prevalence of and factors associated with leaving AMA among PWUD.

Methods

Data were collected through two Canadian prospective cohort studies involving PWUD between September 2005 and July 2011 and linked to a hospital admission/discharge database. Bivariable and multivariable generalized estimating equations were used to examine factors associated with leaving hospital AMA among PWUD who were hospitalized.

Results

Among 488 participants who experienced at least one hospitalization, 212 (43.4%) left the hospital AMA at least once during the study period. In multivariable analyses, factors positively and significantly associated with leaving hospital AMA included: unstable employment (AOR = 1.92; 95% confidence interval [CI]: 1.22–3.03); recent incarceration (AOR = 1.63; 95%CI: 1.07–2.49); ≥ daily heroin injection (AOR = 1.49; 95%CI: 1.05–2.11); and younger age per year younger (adjusted odds ratio [AOR] = 1.04; 95%CI: 1.02–1.06).

Conclusions

We found a substantial proportion of PWUD in this setting left hospital AMA and that various markers of risk and vulnerability were associated with this phenomenon. Our findings highlight the need to address substance abuse issues early following hospital admission. These findings further suggest a need to develop novel interventions to minimize PWUD leaving hospital prematurely.

Introduction

Leaving hospital against medical advice (AMA) remains a major healthcare challenge that often leads to an array of negative health consequences and related costs. Previous studies have documented elevated rates of readmission among patients who leave hospital AMA [13], suggesting that many of these individuals fail to make a full recovery the first time they are treated. The problem of leaving hospital AMA is also associated with high and preventable costs associated with readmission [2], as patients who leave hospital AMA often return with more serious forms of illness that require lengthier stays in hospital than was initially required [3]. Past studies have also indicated an increased risk of mortality among patients who leave hospital AMA compared to those who had a planned discharge [4,5]. It is noteworthy that there may also be mechanisms indirectly (e.g., health-related patient characteristics) related to the acute illness that are associated with these negative health outcomes and thus, may not solely be a direct result of leaving hospital AMA [6].

A growing body of literature indicates that a large proportion of patients with a history of substance use leave hospital AMA [1]. For example, previous research conducted in Vancouver showed that one-quarter of HIV-positive people who inject drugs (PWID) admitted to an inner-city tertiary care hospital were discharged AMA [7]. Other studies have documented that PWID were two to four times more likely to be discharged AMA compared to their non-PWID counterparts [3,7]. From a population health perspective, this is alarming given the known health risks associated with illicit drug use and leaving hospital AMA [810].

Despite the growing body of research dedicated to exploring the complex phenomenon of individuals leaving hospital AMA, at present there are few studies focused specifically on people who use illicit drugs (PWUD) beyond identifying them as being at an increased risk. Additionally, the existing research has relied heavily on retrospective data collected from hospital records. This approach has limitations, including a lack of focus on how more proximal individual factors, as well as broader social, structural and environmental factors, may influence leaving hospital AMA among this population [11]. To address these gaps in the literature, we undertook this study to examine the individual, social, structural and environmental factors that influence leaving hospital AMA among PWUD in Vancouver, Canada. With its universal healthcare system, this setting is unique in that it allows for the investigation of factors associated with these outcomes without the confounding effect of explicit financial barriers to essential medical care. It is hoped that the findings from this study may serve to inform the development of interventions that aim to reduce the rate of PWUD leaving hospital prematurely.

Methods

Study sample

The Vancouver Injection Drug Users Study (VIDUS) and the AIDS Care Cohort to evaluate Exposure to Survival Services (ACCESS) are two open prospective cohort studies of PWID and PWUD who have been recruited through self-referral, street outreach and word-of-mouth since May 1996. These cohorts have been described in detail previously [12,13]. Briefly, to be eligible for enrollment, participants had to be at least 18 years of age and reside in the greater Vancouver region. The recruitment and follow-up procedures for the two studies are largely identical, allowing for combined analyses, with the only difference being that HIV-positive individuals who use illicit drugs other than cannabis in the month prior to enrollment are followed in ACCESS whereas HIV-negative individuals who injected drugs in the month prior to enrollment are followed in VIDUS. All eligible participants provided written informed consent. At baseline and semi-annually thereafter, participants complete a harmonized interviewer-administered questionnaire and provide blood samples for HIV and HCV testing, as well as HIV disease monitoring. Participants were given a stipend ($20 CAN) at each study visit for their time and transportation. Through a confidential linkage, the cohort data was linked to St. Paul’s Hospital admission/discharge database, which records all admissions, diagnoses and discharge information for each patient who was hospitalized at St. Paul’s Hospital. It is noteworthy that while we linked our cohort data to only one hospital, St. Paul’s Hospital is located in the heart of downtown Vancouver and is known to service the majority of PWUD in this setting [14,15]. Written consent was obtained for all data linkages via a Personal Health Number, which is a unique lifetime government-provided identifier for residents in the province of British Columbia. The study was approved by the University of British Columbia/Providence Health Care’s Research Ethics Board.

The present study was restricted to participants who experienced at least one admission to in-patient care at St. Paul’s Hospital between September 2005 and July 2011. Participants’ first admission to St. Paul’s Hospital during the study period was considered their baseline and they were followed forward from that point onward. Despite past research focusing on patients with a history of injection drug use and leaving hospital AMA, we purposefully included both PWID and PWUD in our study given that PWUD who do not inject are also vulnerable to an array of health harms that require hospitalization [10,16]. Moreover, as in the case of PWID, we hypothesized that PWUD who do not inject are also at risk of leaving hospital AMA. For the present study, we will henceforth use PWUD to denote both injectors and non-injectors.

Variable selection

The primary outcome of interest for this analysis was having left hospital AMA during the study period, which was ascertained from the St. Paul’s Hospital database. As defined by St. Paul’s Hospital, participants were designated as leaving hospital AMA if they left the hospital without physician permission and did not return within six hours (e.g., if a participant left the hospital and returned seven hours later they were considered as having left the hospital AMA and their subsequent admission would be considered a new admission to the hospital). Participants were also defined as having left hospital AMA if they did not return to hospital within six hours after obtaining physician permission to leave on a pass (unless the physicians authorized a longer period). This definition is consistent with previous research that examined hospital discharge AMA and readmission rates in this setting [17]. We explored a range of individual, social and structural factors that may potentially be associated with leaving hospital AMA, including: age (per year younger); gender (male vs. female); Aboriginal ancestry (yes vs. no) [3,7]; HIV serostatus (positive vs. negative); in a stable relationship, defined as either legally married/common law or having a regular partner (yes vs. no); homelessness (yes vs. no); ≥ daily heroin injection (yes vs. no); ≥ daily cocaine injection (yes vs. no); ≥ daily crystal methamphetamine injection (yes vs. no); ≥ daily prescription opioid injection, defined as injection of either OxyNeo, OxyContin, Percocet, Tylenol 3, Morphine, Dilaudid, Demerol, Methadone, Fentanyl, Hydrocodone, or Talwin (yes vs. no); ≥ daily crack cocaine non-injection (yes vs. no); binge drug use (yes vs. no); need help injecting (yes vs. no); unstable employment, defined as not having a regular job, temporary job or self-employed (yes vs. no); drug dealing (yes vs. no); sex work (yes vs. no); incarceration (yes vs. no); enrollment in methadone maintenance therapy (MMT) (yes vs. no); difficulty finding drug use paraphernalia, including syringes, needles and crack cocaine pipes (yes vs. no); and ever had negative experiences with healthcare professionals (yes vs. no). All these variables were ascertained from the cohort data and referred to the six months prior to each interview unless otherwise indicated.

Statistical analyses

Bivariable and multivariable statistics were used to identify factors associated with leaving hospital AMA. Since analyses of factors potentially associated with our outcome of interest included serial measures for each subject, we used generalized estimating equations (GEE) for binary outcomes with logit link for the analysis of correlated data to determine factors associated with leaving hospital AMA. These methods provided standard errors adjusted by multiple observations per person using an exchangeable correlation structure. Therefore, data from every participant follow-up visit were considered in this analysis. As a first step, GEE bivariable analyses were conducted to obtain unadjusted odds ratios and 95% confidence intervals for variables of interest. Then, a multivariable model was fit using an a priori-defined statistical protocol based on examination of the quasi-likelihood under the independence model criterion (QIC) for GEE and p-values [18]. First, a preliminary model was constructed including all variables significantly associated with the outcome in bivariable analyses at p < 0.10. Following this, each variable with the highest p-value was removed sequentially, with the final model including the set of variables associated with the lowest QIC. We also quantified the severity of multicollinearity using the variance inflation factor (VIF). All p-values are two-sided.

Results

Between September 2005 and July 2011, a total of 488 PWUD had experienced at least one hospitalization at St. Paul’s Hospital and were included in the study: 211 (43.2%) were female and the median age at baseline was 44 years (interquartile range: 38–50 years). In total, there were 1,176 hospital admissions among these individuals, and during the study period, participants were admitted to the hospital between 1 and 30 times per participant. Among these participants, 212 (43.4%) unique individuals left the hospital AMA at least once during the study period. Table 1 shows the characteristics of the study sample stratified by having ever left hospital AMA.

thumbnail
Table 1. Sample characteristics stratified by having ever left hospital against medical advice (n = 488).

https://doi.org/10.1371/journal.pone.0141594.t001

As indicated in Table 2, in bivariable analyses, factors significantly and positively associated with leaving hospital AMA included: younger age per year younger (odds ratio [OR] = 1.04; 95% confidence interval [CI]: 1.03–1.06); homelessness (OR = 1.51; 95%CI: 1.10–2.08); ≥ daily heroin injection (OR = 1.76; 95%CI: 1.24–2.48); ≥ daily crack cocaine non-injection (OR = 1.43; 95%CI: 1.09–1.89); drug dealing (OR = 1.53; 95%CI: 1.10–2.12); incarceration (OR = 1.90; 95%CI: 1.26–2.85); and unstable employment (OR = 1.79; 95%CI: 1.14–2.78). Enrollment in MMT (OR = 0.73; 95%CI: 0.55–0.98) was negatively associated with the outcome.

thumbnail
Table 2. Bivariable and multivariable GEE analysis of factors associated with leaving hospital against medical advice among hospitalized people who use illicit drugs (n = 488).

https://doi.org/10.1371/journal.pone.0141594.t002

Table 2 also presents multivariable analyses of factors associated with leaving hospital AMA. Variables that remained significantly and positively associated with the outcome included: younger age per year younger (adjusted odds ratio [AOR] = 1.04; 95%CI: 1.02–1.06); daily heroin injection (AOR = 1.49; 95%CI: 1.05–2.11); incarceration (AOR = 1.63; 95%CI: 1.07–2.49); and stable employment (AOR = 1.92; 95%CI: 1.22–3.03). The VIF estimate calculated revealed no significant multicollinearity in our final model.

Discussion

In the present study we found that a substantial proportion of PWUD in our sample had left the hospital AMA at some point during the study period and that various markers of risk and vulnerability were associated with this phenomenon. It is concerning that hospital discharge AMA occurs frequently among this population given the known health-related harms and costs linked to such events, including hospital readmission and mortality [3,5,19]. It is also likely that many PWUD may have left the hospital to maintain their drug use habits and failed to return to the hospital afterward. To address this, a more permissive approach to hospital policies that allow patients to leave for longer periods of time and return for continued treatment without having to be discharged from the hospital AMA might be appropriate. As well, the development and implementation of novel interventions that aim to minimize leaving hospital prematurely among this population is needed.

Findings from our study revealed that high intensity heroin injection was positively associated with leaving hospital AMA. Given the unavailability of illicit opioids in hospital settings as a result of abstinence-based policies in most hospitals, frequent heroin injectors may face severe withdrawal symptoms and as a result, may discharge themselves from hospital AMA to obtain heroin to maintain their drug dependency [20]. The higher odds of leaving hospital AMA among PWUD who are frequent injectors could also be explained by the complexities around treating opioid-dependent patients for pain [2123]. In particular, studies have documented the provision of inadequate pain management among these individuals [23,24], which may ultimately contribute to an increased risk of leaving hospital AMA to self-manage their pain [25]. To prevent these potential concerns, hospitals may benefit from consulting liaison teams with specialized skills in managing opioid withdrawal and pain. As well, clinical guidelines to treat chronic non-cancer pain specific to PWUD may be useful for healthcare providers to more appropriately treat pain for these individuals [26].

Previous studies have indicated that PWUD with a history of incarceration are less likely to access and utilize healthcare services [2729]. Our findings add to the existing literature by revealing a positive relationship between recent incarceration and leaving hospital AMA. This may be due to the negative experiences PWUD contend with in correctional settings, including poor relations between inmates and prison health staff that may create mistrust towards healthcare providers among those previously incarcerated [30]. In addition, recent incarceration may be a marker for more unstable addiction or other comorbidities (e.g., mental illness). Given the limited evidence concerning this dynamic, future research should seek to untangle the precise causal relationships underlying these associations. Nevertheless, a number of interventions that seek to build and improve patient-physician relationships should be considered, including educating physicians on how to effectively identify and appropriately address the needs of PWUD patients. In addition, specialized training in addiction medicine among healthcare providers that may help to remove the stigma and discrimination PWUD sometimes experience in hospitals should be a priority.

Our study found that having unstable employment was a risk factor independently associated with leaving hospital AMA. One explanation for our finding may be that being unstably employed is a marker of greater instability and higher intensity substance abuse [31,32], though further research is needed to tease out these dynamics. Nevertheless, previous studies have demonstrated strong links between unstable employment through street-based income generating activities (e.g., drug dealing, sex work, scavenging), greater exposure to the illicit drug scene and substance abuse [31,33]. Thus, another explanation for our finding may be that, among individuals with unstable employment and who engage in street-based income generation activities, being hospitalized and absent from the drug scene could mean not being able to secure funds for drugs and the loss of a job. As a result, people with unstable employment are more likely to leave hospital AMA to maintain both their job and their drug dependency. However, it is noteworthy that while having stable employment has been shown to be associated with various positive outcomes for PWUD [34], there are a number of barriers to obtaining employment and studies have consistently shown low levels of employment among this population [32,35,36].

There are several limitations to this study. First, we cannot infer causation because of the observational nature of the VIDUS and ACCESS studies. Second, we cannot assess the temporality between the explanatory and outcome variables of interest. Third, our sample was not randomly recruited and therefore may not be representative of all local PWUD. On a related note, there may be a selection bias due to the fact that those who were admitted in hospital may be a sample of high-risk PWUD. Fourth, our survey instrument relied on self-report and thus, may be subject to reporting biases. However, our outcome of interest was ascertained from comprehensive administrative records and therefore is not subject to these biases. Fifth, given that the outcome variable was pre-defined by St. Paul’s Hospital, we could not differentiate between patients who completely left hospital AMA and those who returned after a more liberal timeframe (e.g., returned after six hours). As a result, we may have misclassified patients who returned to the hospital after a delayed period of time and continued their care, who may indeed have different outcomes than those who completely left hospital AMA. Lastly, this research project included only one hospital. This limitation would have resulted in an underestimation of hospital use, as some participants may have accessed other hospitals during the study period. However, as noted above, St. Paul’s Hospital is known to service the majority of PWUD in the study [14,37].

In sum, we found that a substantial proportion of hospitalized PWUD in the study sample left hospital AMA. Younger individuals, those who inject heroin with high frequency, those who were previously incarcerated, and those with unstable employment were more likely to have left hospital AMA. Our findings highlight the need to address substance abuse issues soon following admission to hospital. These findings also suggest a need to develop novel interventions to reduce the rate of PWUD leaving hospital prematurely.

Acknowledgments

The authors thank the study participants for their contribution to the research, as well as current and past researchers and staff. The VIDUS study was supported by the US National Institutes of Health (R01DA011591, U01DA038886). The ACCESS study was supported by the US National Institutes of Health (R01DA021525). LT is supported by a Canadian Institutes of Health Research Fellowship Award. This research was undertaken, in part, thanks to funding from the Canada Research Chairs program through a Tier 1 Canada Research Chair in Inner City Medicine which supports EW.

Author Contributions

Conceived and designed the experiments: LT EW TK. Performed the experiments: LT M-JM KH EW TK. Analyzed the data: LT SD. Contributed reagents/materials/analysis tools: M-JM KH EW TK. Wrote the paper: LT M-JM JB RM SD KH EW TK.

References

  1. 1. Alfandre DJ. “I’m Going Home”: Discharges Against Medical Advice. Mayo Clin. Proc. 2009;84:255–60. pmid:19252113
  2. 2. Aliyu ZY. Discharge against medical advice: sociodemographic, clinical and financial perspectives. Int. J. Clin. Pract. 2002;56:325–7. pmid:12137437
  3. 3. Anis AH, Sun H, Guh DP, Palepu A, Schechter MT, O’Shaughnessy MV. Leaving hospital against medical advice among HIV-positive patients. CMAJ Can. Med. Assoc. J. 2002;167:633–7.
  4. 4. Glasgow JM, Vaughn-Sarrazin M, Kaboli PJ. Leaving Against Medical Advice (AMA): Risk of 30-Day Mortality and Hospital Readmission. J. Gen. Intern. Med. 2010;25:926–9. pmid:20425146
  5. 5. Southern WN, Nahvi S, Arnsten JH. Increased risk of mortality and readmission among patients discharged against medical advice. Am. J. Med. 2012;125:594–602. pmid:22513194
  6. 6. Garland A, Ramsey CD, Fransoo R, Olafson K, Chateau D, Yogendran M, et al. Rates of readmission and death associated with leaving hospital against medical advice: a population-based study. CMAJ Can. Med. Assoc. J. 2013;185:1207–14.
  7. 7. Chan AC, Palepu A, Guh DP, Sun H, Schechter MT, O’Shaughnessy MV, et al. HIV-positive injection drug users who leave the hospital against medical advice: the mitigating role of methadone and social support. J. Acquir. Immune Defic. Syndr. 1999. 2004;35:56–9.
  8. 8. Binswanger IA, Kral AH, Bluthenthal RN, Rybold DJ, Edlin BR. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2000;30:579–81.
  9. 9. Lloyd-Smith E, Kerr T, Hogg RS, Li K, Montaner JS, Wood E. Prevalence and correlates of abscesses among a cohort of injection drug users. Harm. Reduct. J. 2005;2:24. pmid:16281979
  10. 10. Sá de LC, Araújo de TME, Griep RH, Campelo V, Monteiro de CF S. Seroprevalence of hepatitis C and factors associated with this in crack users. Rev. Lat. Am. Enfermagem. 2013;21:1195–202. pmid:24402335
  11. 11. Rhodes T. The “risk environment”: a framework for understanding and reducing drug-related harm. Int. J. Drug Policy. 2002;13:85–94.
  12. 12. Strathdee SA, Palepu A, Cornelisse PG, Yip B, O’Shaughnessy MV, Montaner JS, et al. Barriers to use of free antiretroviral therapy in injection drug users. JAMA J. Am. Med. Assoc. 1998;280:547–9.
  13. 13. Tyndall M, Currie S, Spittal P, Li K, Wood E, O’Shaughnessy M, et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS Lond. Engl. 2003;17:887–93.
  14. 14. Fairbairn N, Milloy M-J, Zhang R, Lai C, Grafstein E, Kerr T, et al. Emergency Department Utilization among a Cohort of HIV-positive Injecting Drug Users in a Canadian Setting. J. Emerg. Med. 2012;43:236–43. pmid:21719229
  15. 15. Palepu A, Tyndall MW, Leon H, Muller J, O’Shaughnessy MV, Schechter MT, et al. Hospital Utilization and Costs in a Cohort of Injection Drug Users. Can. Med. Assoc. J. 2001;165:415–20.
  16. 16. Sordo L, Indave BI, Barrio G, Degenhardt L, de la Fuente L, Bravo MJ. Cocaine use and risk of stroke: a systematic review. Drug Alcohol Depend. 2014;142:1–13. pmid:25066468
  17. 17. Choi M, Kim H, Qian H, Palepu A. Readmission Rates of Patients Discharged against Medical Advice: A Matched Cohort Study. PLoS ONE. 2011;6:e24459. pmid:21931723
  18. 18. Pan W. Akaike’s Information Criterion in Generalized Estimating Equations. Biometrics. 2001;57:120–5. pmid:11252586
  19. 19. Tawk R, Freels S, Mullner R. Associations of mental, and medical illnesses with against medical advice discharges: the National Hospital Discharge Survey, 1988–2006. Adm. Policy Ment. Health. 2013;40:124–32. pmid:22057857
  20. 20. McNeil R, Small W, Wood E, Kerr T. Hospitals as a “risk environment”: An ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugs. Soc. Sci. Med. 2014;105C:59–66.
  21. 21. Carroll IR, Angst MS, Clark JD. Management of perioperative pain in patients chronically consuming opioids. Reg. Anesth. Pain Med. 2004;29:576–91. pmid:15635517
  22. 22. Hines S, Theodorou S, Williamson A, Fong D, Curry K. Management of acute pain in methadone maintenance therapy in-patients. Drug Alcohol Rev. 2008;27:519–23. pmid:18696299
  23. 23. Huxtable CA, Roberts LJ, Somogyi AA, MacIntyre PE. Acute pain management in opioid-tolerant patients: a growing challenge. Anaesth. Intensive Care. 2011;39:804–23. pmid:21970125
  24. 24. McCreaddie M, Lyons I, Watt D, Ewing E, Croft J, Smith M, et al. Routines and rituals: a grounded theory of the pain management of drug users in acute care settings. J. Clin. Nurs. 2010;19:2730–40. pmid:20846223
  25. 25. Voon P, Callon C, Nguyen P, Dobrer S, Montaner J, Wood E, et al. Self-management of pain among people who inject drugs in Vancouver. Pain Manag. 2014;4:27–35. pmid:24641341
  26. 26. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, et al. Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain. J. Pain. 2009;10:113–30.e22. pmid:19187889
  27. 27. Freudenberg N, Daniels J, Crum M, Perkins T, Richie BE. Coming Home From Jail: The Social and Health Consequences of Community Reentry for Women, Male Adolescents, and Their Families and Communities. Am. J. Public Health. 2005;95:1725–36. pmid:16186451
  28. 28. van Olphen J, Eliason MJ, Freudenberg N, Barnes M. Nowhere to go: How stigma limits the options of female drug users after release from jail. Subst. Abuse Treat. Prev. Policy. 2009;4:10. pmid:19426474
  29. 29. Van Olphen J, Freudenberg N, Fortin P, Galea S. Community Reentry: Perceptions of People with Substance Use Problems Returning Home from New York City Jails. J. Urban Health Bull. N. Y. Acad. Med. 2006;83:372–81.
  30. 30. Tompkins C, Neale J, Sheard L, Wright N. Experiences of prison among injecting drug users in England: A qualitative study. Int. J. Prison. Health. 2007;3:189–203.
  31. 31. DeBeck K, Shannon K, Wood E, Li K, Montaner J, Kerr T. Income generating activities of people who inject drugs. Drug Alcohol Depend. 2007;91:50–6. pmid:17561355
  32. 32. Richardson L, Wood E, Li K, Kerr T. Factors associated with employment among a cohort of injection drug users. Drug Alcohol Rev. 2010;29:293–300. pmid:20565522
  33. 33. Ti L, Richardson L, DeBeck K, Nguyen P, Montaner J, Wood E, et al. The impact of engagement in street-based income generation activities on stimulant drug use cessation among people who inject drugs. Drug Alcohol Depend. 2014;
  34. 34. Steensma C, Boivin J, Blais L, Roy E. Cessation of Injecting Drug Use Among Street-Based Youth. J Urban Health. 2005;82:622–37. pmid:16195471
  35. 35. Alexandre PK, French MT. Further evidence on the labor market effects of addiction: chronic drug use and employment in metropolitan Miami. Contemp. Econ. Policy. 2004;22:382–93.
  36. 36. DeSimone J. Illegal Drug Use and Employment. J. Labor Econ. 2002;20:952–77.
  37. 37. Lloyd-Smith E, Wood E, Zhang R, Tyndall MW, Sheps S, Montaner JSG, et al. Determinants of hospitalization for a cutaneous injection-related infection among injection drug users: a cohort study. BMC Public Health. 2010;10:327. pmid:20534148